로딩 중…
StockDiggingStockDigging

Transcat, Inc.

TRNS· NASDAQ
$86.00+0.84%
2026-09-18

Financials

Valuation Metrics

Transcat, Inc.'s Market Cap is $803M. At end of 2025 it was $511M. Ranked #2596 of 3,121 in US market (top 83%), #1095 of 1,463 on NASDAQ (top 75%), #210 of 242 in Capital Goods (top 87%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap$803M
Revenue$348M
Net Income$3M
Total Assets$493M
Net Assets$303M
Employees1,413
Value
P/E232.90x
P/B2.65x
P/S2.30x
EV/EBITDA24.14x
FCF Yield3.16%
Profitability
ROE1.14%
ROA0.70%
Op. Margin3.02%
Revenue Growth20.17%
Earnings Growth-77.77%
Financial Health
Debt Ratio62.64%
Total Debt$143M
FCF$25M
Cash$7M
Current Ratio2.49x
Net Debt/EBITDA3.51x
Performance
1Y Return13.55%
1M Return-6.29%
From 52W High-14.00%
1Y MDD-34.34%
Trading
Volume103,763 shares
Trading Value$9M
Per Share
EPS$0.37
BPS$32.46

Company Info

CEO Jaime A. Irick
Employees 1,413
HQ Rochester, US

Transcat, Inc. offers comprehensive calibration and instrument services for laboratories, serving clients across the United States, Canada, and other international markets. The company operates through two distinct divisions: Service and Distribution. The Service division delivers a wide array of offerings, including precision calibration, equipment repair, thorough inspections, analytical qualification, preventive maintenance, and expert consulting. This segment also features its proprietary software, CalTrak, designed to manage documents and assets while streamlining the operational workflow for its calibration centers and customer equipment. Additionally, its "Compliance, Control and Cost" online portal grants customers web-based asset management capabilities and a secure, off-site repository for calibration and other service records. The Distribution division focuses on the sale and rental of instruments for testing, measurement, and control purposes. It also provides valuable supplementary services such as the calibration and certification of newly purchased equipment, equipment leasing, sales of pre-owned machinery, and customized equipment kitting. This division engages customers through its online platform, various digital and print marketing campaigns, proactive outbound sales efforts, and an incoming call center. Transcat primarily caters to highly regulated sectors, particularly the life sciences—encompassing pharmaceutical, biotechnology, medical device, and other FDA-regulated entities. Furthermore, it extends its services and products to aerospace and defense, industrial manufacturing, energy, utilities, and other industries where process accuracy and confirmed equipment performance are paramount. Established in 1964, Transcat, Inc. maintains its corporate headquarters in Rochester, New York.